Skip to main content

and
  1. No Access

    Article

    Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era

    Multiparametric prostate MRI (mpMRI) is being increasingly adopted for work-up of prostate cancer. For patients selected to omit biopsy, we identified factors associated with repeat MRI, eventual prostate biop...

    Eric V. Li, Anna M. Busza, Mohammad R. Siddiqui in Prostate Cancer and Prostatic Diseases (2024)

  2. No Access

    Article

    Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men

    To develop nomograms that predict the detection of clinically significant prostate cancer (csPCa, defined as ≥GG2 [Grade Group 2]) at diagnostic biopsy based on multiparametric prostate MRI (mpMRI), serum biom...

    Mohammad R. Siddiqui, Eric V. Li in Prostate Cancer and Prostatic Diseases (2023)

  3. No Access

    Article

    Real-world use of MRI for risk stratification prior to prostate biopsy

    The utilization of MRI to risk stratify elevated PSA prior to prostate biopsy has been inconsistently adopted and varies considerably by practice setting. This study aims to evaluate the usage and performance ...

    Mohammad R. Siddiqui, Brandon Ansbro in Prostate Cancer and Prostatic Diseases (2023)

  4. No Access

    Article

    Relationships between holmium laser enucleation of the prostate and prostate cancer

    Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable functiona...

    Matthew S. Lee, Mark A. Assmus, Jenny Guo, Mohammad R. Siddiqui in Nature Reviews Urology (2023)

  5. Article

    Open Access

    Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)

    Bladder cancer (BC) is heterogeneous and expresses various cell surface targets. Photoimmunotherapy (PIT) involves monoclonal antibodies (MAbs) conjugated to a photoabsorber (PA), IR Dye 700Dx, and then activa...

    Mohammad R. Siddiqui, Reema Railkar, Thomas Sanford, Daniel R. Crooks in Scientific Reports (2019)